Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Free Report) insider Robert Patrick Mahoney purchased 20,000 shares of the firm’s stock in a transaction on Monday, August 14th. The stock was bought at an average price of $0.63 per share, for a total transaction of $12,600.00. Following the purchase, the insider now owns 124,576 shares […]
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Free Report) major shareholder David Soane purchased 273,838 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were purchased at an average cost of $0.51 per share, for a total transaction of $139,657.38. Following the transaction, the insider now directly owns 225,648 […]
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Free Report) major shareholder David Soane bought 273,838 shares of the business’s stock in a transaction on Monday, July 31st. The stock was bought at an average cost of $0.51 per share, for a total transaction of $139,657.38. Following the purchase, the insider now directly owns 225,648 […]
Comera Life Sciences (NASDAQ:CMRA – Get Rating) is one of 995 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its competitors? We will compare Comera Life Sciences to related businesses based on the strength of its valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Profitability This table compares […]
Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA – Get Rating) was the target of a large decrease in short interest in April. As of April 15th, there was short interest totalling 46,300 shares, a decrease of 28.9% from the March 31st total of 65,100 shares. Based on an average daily trading volume, of 25,100 shares, the […]